Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.

Cancer epidemiology - 1 Aug 2014

Zhang Kai, Tang Shaowen, Cao Songyu, Hu Lingmin, Pan Yun, Ma Hongxia, Guo Xuejiang, Wu Shuangshuang, Shen Hongbing, Hu Zhibin

Abstract excerpt

BACKGROUND: Cancer-testis (CT) genes are predominantly expressed in the testis and are ectopically activated in a wide range of cancers. The expression of CT antigens has been shown to significantly affect the survival of patients with non-small-cell lung cancer (NSCLC). Recently, a genome-wide association study (GWAS) and expression analysis have identified a novel CT gene (HORMAD2) associated with lung cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antigens, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asian People

Share to Carcinoma, Non-Small-Cell Lung

Share to Kaplan-Meier Estimate

Share to Lung Neoplasms

Share to Prognosis

Share to Proportional Hazards Models

Source

Identifiers

PMID: 24797335
DOI: 10.1016/j.canep.2014.03.013

Genes

HORMAD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.PMID 24797335Read ↗

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancersSemantic proximity Read ↗

CRTC2 and PROM1 expression in non-small cell lung cancer: analysis by Western blot and immunohistochemistry.Semantic proximity Read ↗

Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer.Semantic proximity Read ↗

Analysis of DHX32 as diagnostic gene and independent prognostic factor of lung squamous cell carcinomaSemantic proximity Read ↗

Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for CancersSemantic proximity Read ↗

Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.Semantic proximity Read ↗

Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients.Semantic proximity Read ↗

ACAT2 may be a novel predictive biomarker and therapeutic target in lung adenocarcinomaSemantic proximity Read ↗

A cis-eQTL genetic variant of the cancer-testis gene CCDC116 is associated with risk of multiple cancers.Semantic proximity Read ↗

Association of polymorphisms in the telomere-related gene ACYP2 with lung cancer risk in the Chinese Han population.Semantic proximity Read ↗

A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.Semantic proximity Read ↗

Profiling cancer testis antigens in non–small-cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.